Literature DB >> 17046157

Age-related changes in glycogen synthase kinase 3beta (GSK3beta) immunoreactivity in the central nervous system of rats.

Soo Joo Lee1, Yoon Hee Chung, Kyeung Min Joo, Heon Chang Lim, Gye Sun Jeon, Daejin Kim, Won Bok Lee, Yong Sik Kim, Choong Ik Cha.   

Abstract

Although glycogen synthase kinase 3beta (GSK3beta) is emerging as a prominent drug target in the treatment of neurodegenerative diseases such as Alzheimer's disease (AD) and stroke, very little is known about age-related changes in GSK3beta expression and GSK3beta phosphorylation. Therefore, we examined age-related changes in immunoreactivities for GSK3beta and phosphorylated GSK3beta (pGSK3beta) in the central nervous system. In aged rats, there were significant increases in GSK3beta immunoreactivity in the cell bodies and processes of pyramidal cells in most cortical regions. GSK3beta immunoreactivity was also significantly increased in the pyramidal layer of CA1-3 regions, and the granule cell layer of dentate gyrus. Age-related increases were prominent in lateral septal nuclei, compared to the medial septal nuclei. Interestingly, both GSK3beta and pGSK3beta was increased in the prefrontal cortex, while GSK3beta and pGSK3beta was differentially localized in the cerebellar cortex. The first demonstration of age-related alterations in immunoreactivities for GSK3beta and pGSK3beta in the basal forebrain area and cholinergic projection targets may provide useful data for investigating the pathogenesis of age-related neurodegenerative diseases including AD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17046157     DOI: 10.1016/j.neulet.2006.09.026

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  19 in total

1.  GSK3β Modulates Timing-Dependent Long-Term Depression Through Direct Phosphorylation of Kv4.2 Channels.

Authors:  Giuseppe Aceto; Agnese Re; Andrea Mattera; Lucia Leone; Claudia Colussi; Marco Rinaudo; Federico Scala; Katia Gironi; Saviana Antonella Barbati; Salvatore Fusco; Thomas Green; Fernanda Laezza; Marcello D'Ascenzo; Claudio Grassi
Journal:  Cereb Cortex       Date:  2019-05-01       Impact factor: 5.357

Review 2.  An expanding GSK3 network: implications for aging research.

Authors:  Dylan C Souder; Rozalyn M Anderson
Journal:  Geroscience       Date:  2019-07-17       Impact factor: 7.713

Review 3.  Glycogen synthase kinase-3 signaling in Alzheimer's disease.

Authors:  Elisabetta Lauretti; Ozlem Dincer; Domenico Praticò
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2020-01-30       Impact factor: 4.739

Review 4.  Glycogen synthase kinase-3 as a therapeutic target for cognitive dysfunction in neuropsychiatric disorders.

Authors:  Olivia O'Leary; Yvonne Nolan
Journal:  CNS Drugs       Date:  2015-01       Impact factor: 5.749

5.  Inhibition of sEH via stabilizing the level of EETs alleviated Alzheimer's disease through GSK3β signaling pathway.

Authors:  Cheng-Peng Sun; Xin-Yue Zhang; Jun-Jun Zhou; Xiao-Kui Huo; Zhen-Long Yu; Christophe Morisseau; Bruce D Hammock; Xiao-Chi Ma
Journal:  Food Chem Toxicol       Date:  2021-08-16       Impact factor: 5.572

6.  β-amyloid impairs the regulation of N-methyl-D-aspartate receptors by glycogen synthase kinase 3.

Authors:  Yulei Deng; Zhe Xiong; Paul Chen; Jing Wei; Shengdi Chen; Zhen Yan
Journal:  Neurobiol Aging       Date:  2013-10-01       Impact factor: 4.673

7.  Neuronal NOS Induces Neuronal Differentiation Through a PKCα-Dependent GSK3β Inactivation Pathway in Hippocampal Neural Progenitor Cells.

Authors:  Shin-Young Park; Min-Jeong Kang; Joong-Soo Han
Journal:  Mol Neurobiol       Date:  2016-09-13       Impact factor: 5.590

8.  Light and electron microscopy study of glycogen synthase kinase-3beta in the mouse brain.

Authors:  Emma Perez-Costas; Johanna C Gandy; Miguel Melendez-Ferro; Rosalinda C Roberts; Gautam N Bijur
Journal:  PLoS One       Date:  2010-01-27       Impact factor: 3.240

9.  GSK3 Function in the Brain during Development, Neuronal Plasticity, and Neurodegeneration.

Authors:  Pamela Salcedo-Tello; Abril Ortiz-Matamoros; Clorinda Arias
Journal:  Int J Alzheimers Dis       Date:  2011-05-04

10.  Altered regulation of tau phosphorylation in a mouse model of down syndrome aging.

Authors:  Olivia Sheppard; Florian Plattner; Anna Rubin; Amy Slender; Jacqueline M Linehan; Sebastian Brandner; Victor L J Tybulewicz; Elizabeth M C Fisher; Frances K Wiseman
Journal:  Neurobiol Aging       Date:  2011-08-16       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.